Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
LIFEDRINK COMPANY falls for first time in 5 days as profit-taking outweighs Iris Ohyama's consecutive stake increase reports
LIFEDRINK COMPANY, INC. <2585> fell for the first time in five days. After the close of trading on the 1st, it was disclosed that Iris Ohyama (Aoba-ku, Sendai), a manufacturer and seller of food and beverages, increased its shareholding ratio in the company from 7.70% to 8.70%. Although LIFEDRINK COMPANY's share price rose at the opening, profit-taking became dominant as short-term overheating sentiment intensified following the recent stock price rise. According to the amended report submitted to the Tohoku Finance Bureau, the reporting obligation occurrence date was the 25th. The purpose of holding is stated as "pure investment." Iris Ohyama's shareholding ratio in LIFEDRINK COMPANY had previously been disclosed as having increased from 6.15% to 7.70% on the 31st.
Source: MINKABU PRESS
Related Articles
FX Summary: Yen strengthens to 158.40 range on buying triggered by BOJ Tankan survey
NIPPON FELT surges to daily limit on first rebound in 6 days after DOE 5 Percent acquires over 5% stake
SONY GROUP Surges on Strategic Partnership with TCL in Home Entertainment
OKUWA's FY02/26 Results Fall Short of Guidance
AI-Driven Programs Ignite Volatile Market: Key Points for Tomorrow's Trading
CHUGAI PHARMA extends gains as U.S. FDA approves Eli Lilly's oral obesity drug Founayo
Vitabrid Japan debuts at \1,301, 5.0% below IPO price
QPS HD, Astroscale HD and other space development-related stocks surge on successful Artemis launch attracting investment flowsâ—‡
Active Stocks (Close): SAMCO, REFINVERSE Group, Nxera Pharma and others
Kringle Pharma hits daily limit up on patent registration for chronic spinal cord injury treatment